Title : Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis.

Pub. Date : 2022 Apr 3

PMID : 35368106






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Notably, 6 of 7 pts (86%) who received either allo-SCT3 or a combination therapy of DLIs, 5-azacytidine and venetoclax achieved CR despite poor cytogenetics post-allo-SCT2 (e.g. TP53). venetoclax tumor protein p53 Homo sapiens